1-20 of 46
Plasma Cell Disorders
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Blood-derived Cell-Free DNA is a Superior Biomarker for Non-Invasive DNA Methylation Profiling in Multiple Myeloma

Open Access
Robbe Heestermans, MD, Catharina Olsen, PhD, Shervine Ameli, MD, Jana Succari, MSc, Toon Janssen, PhD, Wouter De Brouwer, Dr., Ann De Becker, Isabelle Vande Broek, Dr., Marleen H Bakkus, Rik Schots, Elke De Bruyne, Ivan Van Riet
Journal: Blood Advances
Blood Adv bloodadvances.2025016480.
https://doi.org/10.1182/bloodadvances.2025016480
Published: 2025
Includes: Supplemental data
Journal Articles

Clinical outcomes in older adults treated outside clinical studies: highlighting the octogenarian experience

Open Access
Dor Shpitzer, Yael C. Cohen, Tamir Shragai, Ori Grossberger, Dana Amsterdam, Anat Reiner-Benaim, Irit Avivi
Journal: Blood Advances
Blood Adv (2025) 9 (11): 2677–2685.
https://doi.org/10.1182/bloodadvances.2025015968
Published: 2025
Includes: Supplemental data
Journal Articles

Immune-aging is linked to clinical malignancy, racial ancestry, and vaccine responses in myeloma

Open Access
Sayalee V. Potdar, Shivani Kapadia, Maryam I. Azeem, Roman Radzievski, Kiran Lakhani, Nisha S. Joseph, Jonathan L. Kaufman, Craig C. Hofmeister, Vikas A. Gupta, Sagar Lonial, Ajay K. Nooka, Kavita M. Dhodapkar, Madhav V. Dhodapkar
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2438–2442.
https://doi.org/10.1182/bloodadvances.2024015680
Published: 2025
Includes: Supplemental data
Journal Articles

Extramedullary Myeloma is Genomically Complex and Characterized by Near-Universal MAPK Pathway Alterations

Open Access
Saurabh Zanwar, Joseph Novak, Wilson I Gonsalves, Michael Howe, Esteban Braggio, S. Vincent Rajkumar, Moritz Binder, Dragan Jevremovic, Surendra Dasari, Shaji K Kumar
Journal: Blood Advances
Blood Adv bloodadvances.2025016619.
https://doi.org/10.1182/bloodadvances.2025016619
Published: 2025
Includes: Supplemental data
Journal Articles

Intrathecal chemotherapy for ciltacabtagene autoleucel-associated movement and neurocognitive toxicity

Open Access
Kaitlin Kelly, Jennifer Cooperrider, Michael R. Bishop, Satyajit Kosuri, Andrzej Jakubowiak, Benjamin A. Derman
Journal: Blood Advances
Blood Adv bloodadvances.2024015721.
https://doi.org/10.1182/bloodadvances.2024015721
Published: 2025
Includes: Supplemental data
Journal Articles

Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma

Open Access
Rahul Banerjee, Alicia Richards, Shonali Midha, Aimaz Afrough, Faiz Anwer, Djordje Atanackovic, Shebli Atrash, Veronika Bachanova, Amer M. Beitinjaneh, Evguenia Bhurtel, Omar Castaneda Puglianini, Saurabh Chhabra, Kara I. Cicero, James A. Davis, Binod Dhakal, Danai Dima, Christopher J. Ferreri, Peter A. Forsberg, Ciara L. Freeman, Megan M. Herr, Tania Jain, Murali Janakiram, Jack Khouri, Mehmet H. Kocoglu, Anupama Kumar, Yuxin Liu, Frederick Locke, Joseph P. McGuirk, Lekha Mikkilineni, Omar Nadeem, Ricardo D. Parrondo, Oren Pasvolsky, Lauren C. Peres, Sneha Purvey, Shahzad Raza, Ran Reshef, Shambavi Richard, Adriana C. Rossi, Douglas W. Sborov, Leyla Shune, Charlotte B. Wagner, Saurabh S. Zanwar, Surbhi Sidana, Krina K. Patel, Doris K. Hansen, Shaji K. Kumar, Yi Lin, Thomas G. Martin, Peter M. Voorhees, Larry D. Anderson, Jr, Andrew J. Cowan, Gurbakhash Kaur
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2336–2340.
https://doi.org/10.1182/bloodadvances.2025016131
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes in Frail Patients Receiving BCMA-directed Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma

Open Access
Benjamin O Adegbite, Carlyn Rose Tan, Tala Shekarkhand, Ross S Firestone, Eric Matthew Jurgens, Kevin C. Miller, Alexander M Lesokhin, Gunjan L Shah, Neha Korde, Sridevi Rajeeve, Heather J Landau, Michael Scordo, Hani Hassoun, Kylee H. Maclachlan, Urvi A Shah, Malin L Hultcrantz, Issam S. Hamadeh, Andriy Derkach, David Nemirovsky, Sergio A. Giralt, Sham Mailankody, Saad Z Usmani, Hamza Hashmi
Journal: Blood Advances
Blood Adv bloodadvances.2025015973.
https://doi.org/10.1182/bloodadvances.2025015973
Published: 2025
Journal Articles

Predictive Value of Free Light Chain Burden in Patients with AL Amyloidosis Treated with Bortezomib-Based Regimens

Open Access
Brendan Saunders, Foteini Theodorakakou, Despina V Fotiou, Samuel Boullt, Benjamin Evans, Meletios Athanasios Dimopoulos, Efstathios Kastritis, Giada Bianchi
Journal: Blood Advances
Blood Adv bloodadvances.2024015528.
https://doi.org/10.1182/bloodadvances.2024015528
Published: 2025
Includes: Supplemental data
Journal Articles

Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort study

Open Access
Amy Song, George Mellgard, Claudia Bellofiore, Marco Basset, Mario Nuvolone, Andrea Foli, Giampaolo Merlini, Mathew S. Maurer, Markus Y. Mapara, Divaya Bhutani, Suzanne Lentzsch, Hiram Shaish, Giovanni Palladini, Rajshekhar Chakraborty, Paolo Milani
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2221–2225.
https://doi.org/10.1182/bloodadvances.2024015646
Published: 2025
Includes: Supplemental data
Journal Articles

Prior exposure to belantamab mafodotin influences outcomes with idecabtagene vicleucel in patients with multiple myeloma

Open Access
Bhavesh Mohan Lal, Marah Alzubi, Jawad Alrawabdeh, John D. Shaughnessy, Jr., Fenghuang Zhan, Eric R. Siegel, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Samer Al Hadidi
Journal: Blood Advances
Blood Adv (2025) 9 (9): 2155–2158.
https://doi.org/10.1182/bloodadvances.2024015648
Published: 2025
Journal Articles

Targeting the RBM39-MEK5 axis synergizes with bortezomib to inhibit the malignant growth of multiple myeloma

Open Access
Jia Liu, Zilu Zhang, Wenbin Xu, Mingyuan Jia, Xinyi Zeng, Chengyu Wu, Ze Fu, Xiaoguang Xu, Chenjing Ye, Chao Wu, Hanzhang Xu, Hu Lei, Yingli Wu, Hua Yan
Journal: Blood Advances
Blood Adv (2025) 9 (8): 1991–2005.
https://doi.org/10.1182/bloodadvances.2025015815
Published: 2025
Includes: Supplemental data
Journal Articles

Teclistamab for Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma and Renal Impairment

Open Access
Danai Dima, Aimaz Afrough, Utkarsh Goel, Ariel Grajales-Cruz, Jack Khouri, Kelley Julian, Oren Pasvolsky, Rahul Banerjee, Beatrice Razzo, Christopher J Ferreri, Mariola Alejandra Vazquez Martinez, James A Davis, Aishwarya Sannareddy, Omar Castaneda Puglianini, Shahzad Raza, Andrew J. Portuguese, Mahmoud R. Gaballa, Masooma Rana, Alex Lieberman-Cribbin, Shaun DeJarnette, Rebecca Gonzalez, Anna Chen, Megan M. Herr, Lakha Mikkilineni, Hitomi Hosoya, Evguenia Ouchveridze, Gurbakhash Kaur, Adriana C Rossi, Leyla Shune, Faiz Anwer, Yi Lin, Shambavi Richard, Douglas W Sborov, Rachid C Baz, Alfred Garfall, Hans C. Lee, Larry D. Anderson, Jr., Andrew J Cowan, Krina K. Patel, Peter M Voorhees, Surbhi Sidana, Doris K Hansen, Shebli Atrash, Sandra P Susanibar-Adaniya
Journal: Blood Advances
Blood Adv bloodadvances.2025016059.
https://doi.org/10.1182/bloodadvances.2025016059
Published: 2025
Includes: Supplemental data
Journal Articles

Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel

Open Access
Satabdi Saha, Lubna Rehman, Abdur Rehman, Faezeh Darbaniyan, Donna M Weber, Melody Becnel, Mahmoud R. Gaballa, Sheeba K Thomas, Hans C. Lee, Chia-Chi Chang, Reetakshi Arora, Meghan Menges, Salvatore Corallo, Marco L. Davila, Frederick L. Locke, Mark R Tanner, Sattva S. Neelapu, Elizabeth J. Shpall, Christopher R. Flowers, Robert Z Orlowski, Robert R Jenq, Michael D Jain, Christine Peterson, Doris K Hansen, Neeraj Y Saini, Krina K. Patel
Journal: Blood Advances
Blood Adv bloodadvances.2024014476.
https://doi.org/10.1182/bloodadvances.2024014476
Published: 2025
Includes: Supplemental data
Journal Articles

Patterns of progression among 427 Smoldering Myeloma patients diagnosed after 2014: importance of monitoring

Open Access
Efstathios Kastritis, Irene Solia, Panagiotis Malandrakis, Foteini Theodorakakou, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Despina V Fotiou, Magdalini Migkou, Dr, Evangelos Eleutherakis Papaiakovou, Vassiliki Spiliopoulou, Nikoletta-Aikaterini Kokkali, Asimina Papanikolaou, Stavroula Giannouli, Maria Gavriatopoulou, Evangelos Terpos, Meletios-Athanasios A. Dimopoulos
Journal: Blood Advances
Blood Adv bloodadvances.2025016083.
https://doi.org/10.1182/bloodadvances.2025016083
Published: 2025
Includes: Supplemental data
Journal Articles

Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes

Open Access
Charalampos Charalampous, Jean-Sebastien Claveau, Prashant Kapoor, Moritz Binder, Francis K. Buadi, Joselle Cook, David Dingli, Angela Dispenzieri, Amie L. Fonder, Morie A. Gertz, Wilson Gonsalves, Suzanne R. Hayman, Miriam A. Hobbs, Yi L. Hwa, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar
Journal: Blood Advances
Blood Adv (2025) 9 (7): 1559–1570.
https://doi.org/10.1182/bloodadvances.2024013355
Published: 2025
Includes: Supplemental data
Journal Articles

Socioeconomic, racial-ethnic, household, and infrastructural disparities of hematologic cancer outcomes in the United States

Open Access
David J. Fei-Zhang, Erik Wu, Alexander V. Stanisic, Lifang Hou, Leonidas C. Platanias, Stephen M. Ansell, Marquita W. Lewis-Thames, Sherif M. Badawy, Jonas Paludo
Journal: Blood Advances
Blood Adv (2025) 9 (6): 1463–1471.
https://doi.org/10.1182/bloodadvances.2024013956
Published: 2025
Includes: Supplemental data
Journal Articles

Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis

Open Access
Tim Richardson, Daniel Schütte, Guido Kobbe, Ben-Niklas Baermann, Tobias A. W. Holderried, Friederike Schmitz, Martina Crysandt, Michael Hallek, Christoph Scheid, Udo Holtick, Oliver A. Cornely, Jannik Stemler, Sibylle C. Mellinghoff
Journal: Blood Advances
Blood Adv (2025) 9 (6): 1370–1375.
https://doi.org/10.1182/bloodadvances.2024015008
Published: 2025
Journal Articles

Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study

Open Access
Clinical Trials & Observations
Vania Hungria, Rafael Gaiolla, Kenny Galvez, Guillermina Remaggi, Natalia Schutz, Rosane Bittencourt, Angelo Maiolino, Guillermo Quintero-Vega, Maria Silvana Cugliari, Walter Moises Tobias Braga, Carolina Colaco Villarim, Edvan Crusoe, Alicia Ines Enrico, Gaston Caiero, Jandey Bigonha, Fernanda Lemos Moura, Jair Figueroa, Claudia Lucia Sossa Melo, Milton Lombana, Huiling Pei, Mariana Fernandez, Jaqueline Saes, Damila Cristina Trufelli
Journal: Blood Advances
Blood Adv (2025) 9 (6): 1293–1302.
https://doi.org/10.1182/bloodadvances.2024013838
Published: 2025
Journal Articles

Restarting Teclistamab and Talquetamab after Prolonged Dose Delay May Not Require Re-Step-up Dosing

Open Access
Carlyn R Tan, Alice X Wang, David Nemirovsky, Andriy Derkach, Tala Shekarkhand, Issam S. Hamadeh, Kylee H. Maclachlan, Malin L Hultcrantz, Hani Hassoun, Sham Mailankody, Alexander M Lesokhin, Urvi A Shah, Sridevi Rajeeve, Hamza Hashmi, Dhwani Patel, Ross S Firestone, Eric Matthew Jurgens, Kevin C. Miller, Gunjan L Shah, Michael Scordo, Heather J Landau, Sergio A. Giralt, Neha Korde, Saad Z Usmani
Journal: Blood Advances
Blood Adv bloodadvances.2024015344.
https://doi.org/10.1182/bloodadvances.2024015344
Published: 2025
Journal Articles

BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement

Open Access
Mahmoud R. Gaballa, Omar Castaneda Puglianini, Adam Cohen, Dan Vogl, Alfred Chung, Christopher J. Ferreri, Peter Voorhees, Doris K. Hansen, Krina K. Patel
Journal: Blood Advances
Blood Adv (2025) 9 (5): 1171–1180.
https://doi.org/10.1182/bloodadvances.2024014345
Published: 2025